发明名称 |
(2S)-2-[[4-[(1R)-1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amin]pentanedioic acid for the treatment of inflammatory disorders |
摘要 |
The present invention relates to diastereomers of 10-propargyl-10-deazaaminopterin, compositions comprising optically pure diastereomers of 10-propargyl-10-deazaaminopterin, in particular the two (R,S) diastereomers about the C10 position, specifically, diastereomers (2S)-2-[[4-[(1S)-1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid and/or (2S)-2-[[4-[(1R)-1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid. Methods of preparation of these diastereomers, compositions containing them, and their use for the treatment of conditions related to inflammatory disorders and cancer are also disclosed. |
申请公布号 |
US9187481(B2) |
申请公布日期 |
2015.11.17 |
申请号 |
US201414467812 |
申请日期 |
2014.08.25 |
申请人 |
Allos Therapeutics, Inc. |
发明人 |
Pronk Gijsbertus J. |
分类号 |
C07D475/08 |
主分类号 |
C07D475/08 |
代理机构 |
Swanson & Bratschun, L.L.C. |
代理人 |
Swanson & Bratschun, L.L.C. |
主权项 |
1. A method for treating an inflammatory disorder in a mammal, comprising administering to a mammal in need of said treatment a therapeutically effective amount of a diastereomer of 10-propargyl-10-deazaaminopterin, or a pharmaceutically acceptable salt thereof, said diastereomer being (2S)-2-[[4-[(1R)-1-[(2,4-diaminopteridin-6-yl)methyl]but-3-ynyl]benzoyl]amino]pentanedioic acid. |
地址 |
Westminster CO US |